stop_circleTerminated/Withdrawn

Bayer Identifier:

91532

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
TOCOSOL paclitaxel and carboplatin in NSCLC

Trial purpose

Key Participants Requirements

Sex

Female

Age

N/A

Trial summary

Enrollment Goal
N/A
Trial Dates
August 2006 - Today
Phase
Phase 2
Could I Receive a placebo
N/A
Products
Tocosol-Paclitaxel (BAY86-5312)
Accepts Healthy Volunteer
N/A

Primary Outcome

  • cycle control and bleeding pattern
    date_rangeTime Frame:
    7 cycles
    enhanced_encryption
    Safety Issue:
    No

Secondary Outcome

  • Pearl index
    date_rangeTime Frame:
    7 cycles
    enhanced_encryption
    Safety Issue:
    No
  • Laboratory tests
    date_rangeTime Frame:
    Screening
    enhanced_encryption
    Safety Issue:
    Yes
  • Adverse Events
    date_rangeTime Frame:
    7 cycles
    enhanced_encryption
    Safety Issue:
    Yes
  • General Physical and gynecological examinations
    date_rangeTime Frame:
    Screening
    enhanced_encryption
    Safety Issue:
    Yes
  • Vital signs
    date_rangeTime Frame:
    Screening, admission
    enhanced_encryption
    Safety Issue:
    Yes
  • Body weight
    date_rangeTime Frame:
    Screening, admission
    enhanced_encryption
    Safety Issue:
    Yes

Trial design

Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
Prevention
Allocation
Randomized
Blinding
Open Label
Assignment
Parallel Assignment
Trial Arms
2

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.